about
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA AnalysisAge- and glycemia-related miR-126-3p levels in plasma and endothelial cells.Socio-Economic and Clinical Factors as Predictors of Disease Evolution and Acute Events in COPD PatientsA molecular epidemiological approach to health risk assessment of urban air pollution.Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy.Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome.Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy.ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis.Effects of environmental benzene: micronucleus frequencies and haematological values in traffic police working in an urban area.Environmental exposure to benzene, micronucleus formation and polymorphisms in DNA-repair genes: a pilot study.Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.Exposure to low environmental levels of benzene: evaluation of micronucleus frequencies and S-phenylmercapturic acid excretion in relation to polymorphisms in genes encoding metabolic enzymes.Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential.Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy.Role of quercetin in modulating rat cardiomyocyte gene expression profile.Micronuclei frequency induced by bleomycin in human peripheral lymphocytes: correlating BLHX polymorphism with mutagen sensitivity.Inherited susceptibility to bleomycin-induced micronuclei: correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity.Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.BRAF mutations are common somatic events in melanocytic nevi.Polymorphisms in DNA repair genes: link with biomarkers of the CBMN cytome assay in hospital workers chronically exposed to low doses of ionising radiation.Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia.MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors.Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting.The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemiaMicronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer riskMicronuclei in humans induced by exposure to low level of ionizing radiation: influence of polymorphisms in DNA repair genesSpectrum of chromosomal aberrations in peripheral lymphocytes of hospital workers occupationally exposed to low doses of ionizing radiationBRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient SurvivalLow frequency ofBRAFandCDKN2Amutations in endometrial cancerSimultaneous detection of the exon 10 polymorphism and a novel intronic single base insertion polymorphism in the XPD gene using single strand conformation polymorphismInfluence of commonXPDandXRCC1variant alleles onp53mutations in lung tumorsPrognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-AnalysisThe rs17084733 variant in the KIT 3' UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility
P50
Q26800005-03FC9062-5C47-4767-B0CB-86C32AA86FB6Q34461150-505B9AE6-A3C7-41FD-87AF-458427D5C132Q35739847-DF1314E0-422A-47B6-9F6F-9D6968D18EEAQ35749330-24FEFD3D-4EFE-4DD8-A02A-4137DC35E760Q36579071-7CEF53F8-5A90-41BC-A5C7-D58E33DB8227Q36695209-BE98BB00-1700-489B-A5DE-63B082DDB2AFQ38112821-7BDF55E4-0039-4436-A3AD-717D806164DBQ38253243-73FB07FF-D4D4-4234-B89D-4C5DCF6E2EFEQ39715306-991ACAE9-4912-4703-81B7-EC715488F6F1Q40016127-B4BC2A56-04B6-4E5D-9FA7-7B7D80891462Q40606325-09F7A294-C38B-4708-8A5F-36B599EB6695Q43776759-F3809D78-ED4E-4E6A-B120-F712A66CC0CEQ43871606-1DBBD0A2-F32F-4580-8016-5F97CBC2BD15Q45014174-AA920861-EE45-4D14-93C3-6241C9B60C52Q45180974-F1301604-8D00-4632-9CDB-6B0C37C8103FQ46820271-B57A4D92-1403-431C-A443-FEED68C58A02Q46848266-EE817952-C8C1-406C-8829-A70DEF353EB5Q46937265-552A2054-303E-48F0-AD99-F8C4F3BA806AQ47801493-9DADC181-BB27-41B7-8C34-BB0700A56011Q47978923-3961F469-D14F-485E-909D-D593E53B70C3Q52935119-067B2AE9-FEF5-46E7-B4CB-3CC9630E02DEQ53796172-9965B2A0-769D-43E3-AE85-952B49846D03Q54280261-CA853CCD-46B6-42BC-96B4-D2CB22C81B8FQ54655331-FFB1675B-FA8A-4935-A579-5924EF57033AQ55654370-01C6916B-EC39-4D98-991F-61C8751DE070Q56973578-196D4F62-5893-4889-815F-D7554C70C6FAQ56974603-362A84D1-861A-44A7-B1A7-3E1ECC4E5AE9Q57000429-8844E464-62C4-4F69-A67A-09E5278EFF46Q57002248-511CED7D-8DCB-4FED-86AB-F700782B7082Q57664873-89521EAF-24B5-4DCA-B41F-FE99DD0655BDQ57664882-B47A9CE6-14E1-42B0-871B-B10D2C30A641Q57664908-E9A8C3A2-750A-4290-81A1-989A1BB16D09Q61643504-49B9A7E4-0978-4542-9381-7CA8A1317C39Q92127478-CC6C9893-4E31-4684-87E5-69F494B8CE86Q93084997-028688DC-0618-47DD-AA4D-80B4C559EE26
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Sabrina Angelini
@ast
Sabrina Angelini
@en
Sabrina Angelini
@es
Sabrina Angelini
@nl
Sabrina Angelini
@sl
type
label
Sabrina Angelini
@ast
Sabrina Angelini
@en
Sabrina Angelini
@es
Sabrina Angelini
@nl
Sabrina Angelini
@sl
prefLabel
Sabrina Angelini
@ast
Sabrina Angelini
@en
Sabrina Angelini
@es
Sabrina Angelini
@nl
Sabrina Angelini
@sl
P106
P1153
7004172232
P21
P214
120152138654210982612
P31
P496
0000-0002-1609-0421
P734
P735
P7859
viaf-120152138654210982612